VIR — Vir Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Vir Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	383	737	708	2,402	1,522
Net Total Accounts Receivable
Net Total Receivables	—	—	773	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	403	772	1,563	2,519	1,588
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.3	79.9	130	188	167
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	512	919	1,954	2,802	1,919
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	59.2	99.1	341	511	175
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	88.1	202	522	724	329
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	424	717	1,432	2,078	1,590
Total Liabilities & Shareholders' Equity	512	919	1,954	2,802	1,919
Total Common Shares Outstanding